Conversant

Conversant Bio (Conversant Biologics, Inc.) was a premier provider of human biospecimens and research services for the pharmaceutical and biotechnology industries. Based in Huntsville, Alabama, the company specialized in the procurement and analysis of high-quality human primary cells, blood, and tissue samples, which were heavily annotated with clinical and genetic data to support drug discovery. In 2018, Conversant Bio merged with Folio Biosciences, Phylogeny, and Discovery Life Sciences to form a global market leader under the Discovery Life Sciences brand. The company was recognized for its extensive clinical network of over 70 IRB-reviewed sites and its focus on accelerating research in oncology, hematology, and immunology.